| Serial Number | 98050400 |
| Word Mark | MABEXPRESS |
| Filing Date | Tuesday, June 20, 2023 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, March 18, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 18, 2025 |
| Goods and Services | Custom manufacture of biopharmaceuticals; consultancy relating to biopharmaceutical manufacturing; consultancy relating to the manufacturing of therapeutics; custom biopharmaceutical drug manufacturing services |
| Goods and Services | Scientific laboratory services relating to the production of monoclonal antibodies; product development services in the nature of biodevelopment services relating to the production of monoclonal antibodies; consultancy relating to biopharmaceutical research and development; biopharmaceutical drug development services; conducting of quality control tests for others; quality control services for others; quality assurance services in the field of biopharmaceuticals; testing, analysis and validation of biopharmaceuticals related to the development and production of monoclonal antibodies; research and development of therapeutics and consultancy related thereto |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, July 23, 2023 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, July 23, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Merck KGaA |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | 64293 Darmstadt F128/002 DE |
| Party Name | Merck KGaA |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | 64293 Darmstadt F128/002 DE |
| Event Date | Event Description |
| Friday, June 23, 2023 | NEW APPLICATION ENTERED |
| Sunday, July 23, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, December 21, 2023 | ASSIGNED TO EXAMINER |
| Friday, January 19, 2024 | NON-FINAL ACTION WRITTEN |
| Friday, January 19, 2024 | NON-FINAL ACTION E-MAILED |
| Monday, September 9, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, September 9, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, January 19, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, April 15, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, September 9, 2024 | ASSIGNED TO LIE |
| Monday, January 6, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, January 22, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, January 28, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, January 28, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, March 12, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 18, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 18, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |